Alonzo D Garcia

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. pmc Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines
    Alonzo D Garcia
    Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics and Evaluation and Research FDA, 1401 Rockville Pike, HFM 457, Rockville, MD 20892, USA
    Clin Vaccine Immunol 14:1032-44. 2007
  2. pmc Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model
    Clement A Meseda
    Laboratory of DNA Viruses, Division of Viral Products, HFM 457, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA
    Clin Vaccine Immunol 16:1261-71. 2009
  3. pmc Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model
    Clement A Meseda
    Division of Viral Products, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
    PLoS ONE 8:e67984. 2013
  4. ncbi request reprint Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model
    Clement A Meseda
    Laboratory of DNA Viruses, Division of Viral Products, HFM 457 Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Bethesda, MD 20892, USA
    Virology 339:164-75. 2005

Detail Information

Publications4

  1. pmc Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines
    Alonzo D Garcia
    Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics and Evaluation and Research FDA, 1401 Rockville Pike, HFM 457, Rockville, MD 20892, USA
    Clin Vaccine Immunol 14:1032-44. 2007
    ..The resulting polyclonal antisera were used in Western blot analysis and immunofluorescence assays, indicating that rSFV particles are useful vectors for generating monospecific antisera...
  2. pmc Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model
    Clement A Meseda
    Laboratory of DNA Viruses, Division of Viral Products, HFM 457, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, USA
    Clin Vaccine Immunol 16:1261-71. 2009
    ..Taken together, the results extend our current understanding of the protective immune responses elicited by LC16m8 and indicate that the relative efficacy in a mouse model rivals that of previously licensed smallpox vaccines...
  3. pmc Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model
    Clement A Meseda
    Division of Viral Products, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland, United States
    PLoS ONE 8:e67984. 2013
    ....
  4. ncbi request reprint Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model
    Clement A Meseda
    Laboratory of DNA Viruses, Division of Viral Products, HFM 457 Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Bethesda, MD 20892, USA
    Virology 339:164-75. 2005
    ..In addition, both Dryvax and various MVA vaccination protocols elicited antibody responses to the extracellular enveloped form of the virus and afforded protection against a lethal intranasal challenge with vaccinia virus WR...